Evidence map›Paper›PMID 40189496›Full record

SynthesisBMC urology2025

Optimal stenting duration following ureteroscopy and nephrolithotomy: systematic review and meta-analysis.

Breno C Porto, Nathalie C Hobaica, Carlo C Passerotti, Rodrigo A S Sardenberg, Jose P Otoch, Jose Arnaldo Shiomi da Cruz

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Breno C PortoSurgical Technique and Experimental Surgery Department, University of São Paulo School of Medicine, São Paulo, SP, Brazil.
Nathalie C HobaicaSurgical Technique and Experimental Surgery Department, University of São Paulo School of Medicine, São Paulo, SP, Brazil.
Carlo C PasserottiSurgical Technique and Experimental Surgery Department, University of São Paulo School of Medicine, São Paulo, SP, Brazil.
Rodrigo A S SardenbergInternational Teaching and Research Institute - Hapvida NotreDame Intermédica, São Paulo, Brazil.
Jose P OtochSurgical Technique and Experimental Surgery Department, University of São Paulo School of Medicine, São Paulo, SP, Brazil.
Jose Arnaldo Shiomi da CruzSurgical Technique and Experimental Surgery Department, University of São Paulo School of Medicine, São Paulo, SP, Brazil. arnaldoshiomi@yahoo.com.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe optimal duration for ureteral stent placement following ureteroscopy remains unclear, with no consensus on its impact on patient outcomes. This study aims to evaluate the ideal stent duration by comparing post-procedure-related events (PREs) and complications.

methodsA comprehensive search of MEDLINE, Embase, Scopus, Cochrane, Web of Science, and Google Scholar identified studies comparing different durations of ureteral stenting after ureteroscopy. The primary outcome was the occurrence of PREs, while secondary outcomes focused on associated complications.

resultsFour studies were included, encompassing 1762 patients with stents removed with ≤ 5 days and 2231 patients with stents removed with ≥ 6 days. The incidence of PREs did not significantly differ between the two groups (OR: 1.26; 95% CI: 0.22-7.25; p = 0.79; I² = 98%). Patients with stent durations ≥ 6 days had higher rates of flank pain and hematuria. In contrast, fever and dysuria were more prevalent in patients with stents removed within 5 days.

conclusionAlthough no significant difference was observed in overall PRE rates, the distinct patterns of complications based on stent duration highlight the complexity of determining optimal stent placement time in clinical practice.

Indexed as

Kidney CalculiNephrolithotomy, PercutaneousPostoperative ComplicationsStentsUreteroscopyHumansTime FactorsPercutaneous nephrolithotomyStentUreterUreteroscopy

Identifiers

PMID40189496
PMCPMC11974034

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.